VI
AMED

Vestcor Inc’s Amedisys AMED Stock Holding History

Vestcor Inc’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-799
Closed -$74K – 1155
2025
Q1 		$74K Hold
799
– – ﹤0.01% 1085
2024
Q4 		$73K Buy
+799
New +$73.4K ﹤0.01% 1121
2024
Q1 		– Sell
-6,459
Closed -$614K – 1248
2023
Q4 		$614K Buy
6,459
+1,124
+21% +$105K 0.02% 592
2023
Q3 		$498K Buy
+5,335
New +$493K 0.02% 627
2022
Q1 		– Sell
-1,123
Closed -$182K – 1431
2021
Q4 		$182K Sell
1,123
-126
-10% -$20.2K 0.01% 886
2021
Q3 		$186K Hold
1,249
– – 0.01% 860
2021
Q2 		$306K Hold
1,249
– – 0.01% 761
2021
Q1 		$331K Hold
1,249
– – 0.01% 712
2020
Q4 		$366K Hold
1,249
– – 0.02% 603
2020
Q3 		$295K Hold
1,249
– – 0.01% 580
2020
Q2 		$248K Buy
+1,249
New +$233K 0.01% 554

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Vestcor Inc's AMED Position: Q2 2025 in Review

Vestcor Inc sold out of Amedisys (AMED) in Q2 2025, closing a stake of 799 shares — an estimated $74K sold.

Vestcor Inc first reported a position in AMED in Q2 2020 and held it in 11 quarters. The position peaked at $614K in Q4 2023. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Vestcor Inc reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Vestcor Inc sold 799 Amedisys shares in Q2 2025, an estimated $74K.
  • Vestcor Inc first reported a position in Amedisys in Q2 2020 and held it in 11 quarters.
  • Vestcor Inc's Amedisys position peaked at $614K in Q4 2023.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Vestcor Inc's 13F filing for Q2 2025, filed 8 Aug 2025.